ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2021 Insights on COVID-19 Vaccines - Opportunity Assessment and Forecast to 2026 - ResearchAndMarkets.com

July 14, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Jul 14, 2021--

The “Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.

This report gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.

The publisher forecasts three different potential scenarios for the future use of COVID-19 vaccines:

  • The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
  • The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
  • In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.

ADVERTISEMENT

Companies Mentioned

  • Pfizer
  • BioNTech
  • Moderna
  • AstraZeneca
  • Johnson & Johnson
  • Novavax
  • CureVac
  • Sanofi
  • GlaxoSmithKline
  • Arcturus
  • Medicago
  • Valneva
  • Inovio

This report includes:

  • Executive Summary
  • Disease Overview: History of the outbreak, Etiology and Pathophysiology
  • Epidemiology
  • Current Vaccination Options: Includes detailed product profiles with SWOT analysis
  • Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
  • Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
  • R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
  • Market Outlook

Reasons to Buy

ADVERTISEMENT

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Topics Covered:

1. Executive Summary

2. Disease Overview

3. Epidemiology

4. Current Vaccination Options

5. Unmet Needs and Opportunities

6. Pipeline Assessment

7. R&D Strategies

8. Market Outlook

9. Appendix

10. Contact the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/an2xjw.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210714005747/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE RESEARCH PHARMACEUTICAL GENERAL HEALTH HEALTH INFECTIOUS DISEASES OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 07/14/2021 12:02 PM/DISC: 07/14/2021 12:03 PM

http://www.businesswire.com/news/home/20210714005747/en